Maravai LifeSciences (MRVI) News Today $5.57 -0.24 (-4.13%) (As of 03:03 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Maravai LifeSciences (NASDAQ:MRVI) Shares Down 4.8% - Time to Sell?Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 4.8% - Here's WhyDecember 18 at 2:20 PM | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Stock Price Up 3.8% - Here's What HappenedMaravai LifeSciences (NASDAQ:MRVI) Shares Up 3.8% - Still a Buy?December 17 at 3:09 PM | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by BrokeragesShares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) have received a consensus rating of "Hold" from the ten analysts that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold ratingDecember 17 at 2:39 AM | marketbeat.comInvestors Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock investors acquired 1,002 put options on the stock. This is an increase of 1,791% compared to the average volume of 53 put options.December 12, 2024 | marketbeat.comQuantinno Capital Management LP Has $2.80 Million Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Quantinno Capital Management LP boosted its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 610.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 336,527 shares of the company's stock aDecember 10, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Fmr LLCFmr LLC cut its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 6.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,479,235 shares of the company's stock after sellinDecember 10, 2024 | marketbeat.comPoint72 Asset Management L.P. Cuts Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Point72 Asset Management L.P. cut its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 70.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,026,749 shares of the company's stock after selliDecember 8, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Lowered to "Sell" Rating by The Goldman Sachs GroupDecember 8, 2024 | americanbankingnews.comCraig-Hallum Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI)December 6, 2024 | markets.businessinsider.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Acquired by Systematic Financial Management LPSystematic Financial Management LP lifted its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 14.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,612,161 shares oDecember 6, 2024 | marketbeat.comGoldman Sachs Downgrades Maravai LifeSciences Holdings (MRVI)December 6, 2024 | msn.comMaravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of DirectorsDecember 5, 2024 | globenewswire.comReadystate Asset Management LP Purchases New Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Readystate Asset Management LP acquired a new position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 138,422 shares of the company's stock, valuDecember 5, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Stock Price Down 3.5% - Should You Sell?Maravai LifeSciences (NASDAQ:MRVI) Shares Down 3.5% - Time to Sell?November 29, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Braidwell LPBraidwell LP cut its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 7.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 8,353,287 shares of the company's stock after selling 670,750 shares during the period. Maravai LifeScienNovember 29, 2024 | marketbeat.comInvestors Purchase Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI)Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the target of some unusual options trading on Wednesday. Stock traders purchased 1,002 put options on the stock. This is an increase of approximately 1,791% compared to the typical volume of 53 put options.November 28, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Position Reduced by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA lessened its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 20.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,601,72November 26, 2024 | marketbeat.comMaravai LifeSciences: Still Struggling To Find Its FootingNovember 25, 2024 | seekingalpha.comMRVI Maravai LifeSciences Holdings, Inc.November 24, 2024 | seekingalpha.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stake Lowered by Jennison Associates LLCJennison Associates LLC decreased its stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 34.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,980,645 shares of the company's stockNovember 23, 2024 | marketbeat.comPrincipal Financial Group Inc. Has $2.93 Million Stock Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Principal Financial Group Inc. cut its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 47.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 352,600 shares of the coNovember 23, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Average Recommendation of "Moderate Buy" from AnalystsMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eleven analysts that are currently covering the firm, Marketbeat reports. Five analysts have rated the stock with a hold recommendation and six have assigned aNovember 22, 2024 | marketbeat.comRoyce & Associates LP Raises Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Royce & Associates LP grew its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 130.4% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 908,778 shares of the company's stock after acquiring an additional 514,332November 18, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Stock Price Down 7.5% - Here's What HappenedMaravai LifeSciences (NASDAQ:MRVI) Trading Down 7.5% - Here's What HappenedNovember 15, 2024 | marketbeat.comMaravai Lifesciences initiated with a Peer Perform at Wolfe ResearchNovember 15, 2024 | markets.businessinsider.comWolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform RecommendationNovember 15, 2024 | msn.comMaravai LifeSciences (NASDAQ:MRVI) Coverage Initiated by Analysts at Wolfe ResearchWolfe Research assumed coverage on shares of Maravai LifeSciences in a research note on Thursday. They set a "peer perform" rating for the company.November 14, 2024 | marketbeat.comMaravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI)Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the target of unusually large options trading on Wednesday. Stock traders acquired 1,002 put options on the company. This represents an increase of approximately 1,791% compared to the typical daily volume of 53 put options.November 14, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying ActivityMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Up After Insider Buying ActivityNovember 13, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Insider Buys $987,000.00 in StockNovember 13, 2024 | insidertrades.comMaravai LifeSciences Announces November 2024 Investor Conference ScheduleNovember 12, 2024 | globenewswire.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | msn.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target PriceNovember 10, 2024 | finance.yahoo.comMaravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comHold Rating on Maravai Lifesciences: Revenue Miss, Guidance Cut, and Market Challenges Amid Potential Upside from Officinae Bio AcquisitionNovember 9, 2024 | markets.businessinsider.comMaravai Lifesciences price target lowered to $13 from $17 at RBC CapitalNovember 9, 2024 | markets.businessinsider.comMaravai LifeSciences Shares Plunge 39% After Guidance Cut, 3Q MissNovember 9, 2024 | marketwatch.comBank of America Securities Reaffirms Their Buy Rating on Maravai Lifesciences Holdings (MRVI)November 9, 2024 | markets.businessinsider.comWilliam Blair Downgrades Maravai LifeSciences Holdings (MRVI)November 9, 2024 | msn.comMaravai LifeSciences stock plunges 39% amid lowered revenue forecastNovember 9, 2024 | seekingalpha.comMaravai Lifesciences Holdings (MRVI) Gets a Buy from Craig-HallumNovember 9, 2024 | markets.businessinsider.comRoyal Bank of Canada Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock PriceRoyal Bank of Canada decreased their price target on Maravai LifeSciences from $17.00 to $13.00 and set an "outperform" rating for the company in a research note on Friday.November 8, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Down After Analyst DowngradeMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Down on Analyst DowngradeNovember 8, 2024 | marketbeat.comRobert W. Baird Cuts Maravai LifeSciences (NASDAQ:MRVI) Price Target to $9.00Robert W. Baird decreased their price target on shares of Maravai LifeSciences from $10.00 to $9.00 and set an "outperform" rating on the stock in a research note on Friday.November 8, 2024 | marketbeat.comWilliam Blair Reiterates Market Perform Rating for Maravai LifeSciences (NASDAQ:MRVI)William Blair reiterated a "market perform" rating on shares of Maravai LifeSciences in a research note on Friday.November 8, 2024 | marketbeat.comMaravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid ResearchNovember 8, 2024 | finance.yahoo.comCannon Global Investment Management LLC Buys New Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Cannon Global Investment Management LLC bought a new stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 71,000 shares of the coNovember 3, 2024 | marketbeat.comRoubaix Capital LLC Has $1.98 Million Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Roubaix Capital LLC trimmed its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 45.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 237,747 shares of the company's stockOctober 31, 2024 | marketbeat.comMaravai LifeSciences (MRVI) to Release Earnings on ThursdayMaravai LifeSciences (NASDAQ:MRVI) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=635822)October 31, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Trading 7% Higher - Here's WhyMaravai LifeSciences (NASDAQ:MRVI) Trading Up 7% - What's Next?October 30, 2024 | marketbeat.com Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW MRVI Media Mentions By Week MRVI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRVI News Sentiment▼1.000.55▲Average Medical News Sentiment MRVI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRVI Articles This Week▼44▲MRVI Articles Average Week Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VKTX News TGTX News BBIO News GRFS News CRNX News ALKS News AXSM News RARE News APLS News PBH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRVI) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maravai LifeSciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maravai LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRVI Stock Alerts